Rivastigmine in the Treatment of Dementia: From the Symptomatic Effect to Neuroprotection

Abdullayeva N. N; Kasimov A. A; Bozorova S. N; Jumanova G. E

Detail Publikasi

Jurnal: Scholastic: Journal of Natural and Medical Education

ISSN: 2835-303X

Volume: 2, Issue: 6

Tanggal Terbit: 30 June 2023

Abstrak

Dementia is a hot topic today, largely as a result of the ageing of the population. One of the most common causes of dementia is Alzheimer's disease (AD). This disease, which is classified as a primary degenerative dementia, is characterized by a progressive decline in cognitive functions, primarily memory, and the development of behavioral disorders.
 


Kata Kunci
dementia mild cognitive impairment treatment rivastigmine
Dokumen Lengkap